Persistent URL of this record https://hdl.handle.net/1887/3753306
Documents
In Collections
This item can be found in the following collections:
Trastuzumab deruxtecan in patients with HER2-mutant metastatic non-small-cell lung cancer: primary results from the randomized, phase II DESTINY-Lung02 trial
- All authors
- Goto, K.; Goto, Y.; Kubo, T.; Ninomiya, K.; Kim, S.W.; Planchard, D.; Ahn, M.J.; Smit, E.F.; Langen, A.J. de; Pérol, M.; Pons-Tostivint, E.; Novello, S.; Hayashi, H.; Shimizu, J.; Kim, D.W.; Kuo, C.H.; Yang, J.C.H.; Pereira, K.; Cheng, F.C.; Taguchi, A.; Cheng, Y.K.; Feng, W.Q.; Tsuchihashi, Z.; Jänne, P.A.
- Date
- 2023-11-01
- Journal
- Journal of Clinical Oncology
- Volume
- 41
- Issue
- 31
- Pages
- 4852 - 4863